Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTLA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF605 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRSK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPKA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRTAP7-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZDHHC14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCHH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MAP3K9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALKBH3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060019 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STKLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on